June 28, 2022
This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022
Summaries of recently reported ECOG-ACRIN research results
December 15, 2021
Summaries of leukemia, lymphoma, and myeloma research results
October 14, 2019
The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.